ALK-Abello
Stage
Incubator/Accelerator | AliveAbout ALK-Abello
ALK-Abello is a company that focuses on the healthcare sector, specifically in the field of allergy solutions. The company offers a range of products and services including diagnostics, allergy vaccines, and consumer healthcare products designed to manage and treat allergies. ALK-Abello primarily serves the healthcare industry. It is based in Horsholm, Denmark.
Loading...
Loading...
ALK-Abello Patents
ALK-Abello has filed 29 patents.
The 3 most popular patent topics include:
- dosage forms
- drug delivery devices
- fluoroquinolone antibiotics

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
9/20/2017 | 6/28/2022 | Auditory system, Ear, Dosage forms, Drug delivery devices, Hepatotoxins | Grant |
Application Date | 9/20/2017 |
---|---|
Grant Date | 6/28/2022 |
Title | |
Related Topics | Auditory system, Ear, Dosage forms, Drug delivery devices, Hepatotoxins |
Status | Grant |
Latest ALK-Abello News
Nov 15, 2023
(marketscreener.com) Stocks in the Nordic region increased Wednesday, with the OMX Nordic 40 Index rising 0.4%. ALK-Abello A/S Series B was the biggest leader during the session, jumping 16.7%, and Zealand Pharma A/S rose 5.5%. NCAB Group AB rounded out the top three leaders on Wednesday, with shares adding 4.9%. Austevoll Seafood ASA posted the largest...https://www.marketscreener.com/news/latest/Nordic-Shares-Closed-Up-Wednesday-ALK-Abello-Series-B-Led-Increases--45363259/?utm_medium=RSS&utm_content=20231115
ALK-Abello Frequently Asked Questions (FAQ)
Where is ALK-Abello's headquarters?
ALK-Abello's headquarters is located at Boge Alle 6-8, Horsholm.
What is ALK-Abello's latest funding round?
ALK-Abello's latest funding round is Incubator/Accelerator.
Who are the investors of ALK-Abello?
Investors of ALK-Abello include Sirti.
Loading...
Loading...